Last reviewed · How we verify
NCT03024749: SUIT-SAVM
Surgical Intervention of Spinal Arteriovenous Malformations and Fistulas
trial in Spinal Cord Vascular Diseases in 380 participants. Status unknown.
31 December 2018
Quick facts
| Lead sponsor | Hongqi Zhang, MD |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 380 |
| Start date | 1 December 2016 |
| Primary completion | 31 December 2018 |
| Estimated completion | 31 December 2019 |
| Sites | 1 location across China |
Conditions studied
- Spinal Cord Vascular Diseases — all drugs for Spinal Cord Vascular Diseases →
Sponsor
Hongqi Zhang, MD
Who can join
Eligibility, any sex, with Spinal Cord Vascular Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Spinal arteriovenous fistulas (AVFs) and arteriovenous malformations (AVMs) are complex neurosurgical lesions that are very challenging to manage. Spinal vascular malformations account for 3%-4% of all intradural spinal cord mass lesions. Over the last few decades our understanding of these lesions has dramatically increased thanks to neuroimaging technology (e.g. spinal angiography and indocyanine green angiography). Various treatment modalities including conservative observation, endovascular embolization, microsurgical resection, radiation therapy, and combined therapies have been reported. The treatment for these AVMs and AVFs depends on their location, the type of malformation, the area of the spine involved, and the condition of the patient at the time of treatment. Due to the rarity of these spinal vascular lesions, reports of their management and outcomes have been limited to small series and case reports. And the rates of obliteration and outcomes are not satisfactory, especially the spinal AVMs. Spinal vascular lesions are rare but represent a formidable challenge for the treating neurosurgeon.The purpose of this study is to establish multimodality treatment mode and evaluate the anatomical cure rate and functional preservation rate.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03024749
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Hongqi Zhang, MD trials
Trials by the same sponsor.
- NCT03192800 — Clinical Outcome in Patients With Spinal Dural Arteriovenous Fistulas (COPSDAVF) · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03024749 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hongqi Zhang, MD
- Last refreshed: 6 June 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03024749.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing